TEKLYNX to sponsor Medical Device and Diagnositc Labeling Conference
10 September 2015
It is 2 weeks until the September 24, 2015* deadline when all implantable, life-supporting/life-sustaining medical devices must bear a UDI label.
With this in mind, TEKLYNX continually strives to learn more about the medical device industry so we can better serve our customers. From September 24-25, 2015, TEKLYNX will be a sponsor of the 3rd Semi-Annual Medical Device and Diagnostic Labeling Conference in San Diego, CA along with our partners: Zebra Technologies, UDI Compliance Solutions, and VantageID to provide a complete UDI solution. Be sure to stop by if you will be attending!
TEKLYNX Enterprise Product Manager, Nick Recht, will be speaking at the labeling break-out session: Sharing Experience & Strategies, where smaller groups and delegates from each industry sector will select topics specific to devices or diagnostics to thoroughly examine and discuss further in an un-conference format. The topic Nick will be speaking about is enterprise integration and print automation. If you will be there, be sure not to miss it!
After the conference closes, we will be continuing the conversations on Friday evening by hosting a Happy Hour with our conference partners UDI Compliance Solutions, Zebra Technologies, and VantageID. If you're planning to attend the conference or are in the San Diego area, contact TEKLYNX Marketing Program Manager, Lindsay Schuemann, at email@example.com for more details.
*The FDA has announced a 30-day extension to the deadline for submission of data to the GUDID (Global Unique Device Identifier Database) only. The September 24, 2015 deadline still applies all other aspects of UDI, including medical device labeling and direct marking.
ABOUT THE CONFERENCE
With the large variety of device and diagnostics on the market, and the ongoing development of new products every year, patients and healthcare professionals need to clearly understand how to handle and utilize medical products safely. This crucial information is conveyed through labels and instructions for use that must respond to an increasing number of complex rules. Labels also serve to enable health authorities, manufacturers and professionals to track products throughout the entire product life-cycle. Ultimately, enhanced traceability facilitates timely post-market surveillance and product recalls, as well as assists in the fight against global medical product counterfeiting. With the release of the FDA UDI rule in 2013, device and diagnostic corporations have had to overcome the challenge of developing new strategies to include this feature in labels, along with implementing the technology that UDI involves. While certain classes of products have reached UDI compliance dates, others are still in the process of building internal processes.
Visit the Q1 Productions website to learn more about the conference: http://www.q1productions.com/conferencepost/labeling-west/#.VfBeiPlVhHw